News
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in ...
A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...
Should the approach translate to humans, people with allergies may one day be able to take a vaccine that protects them from dangerous allergic reactions.
For millions of people around the world, asthma is more than just a breathing problem—it is a chronic and often debilitating ...
Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results